U.S. judge in Anthem merger trial sets trial for November 21, plans ruling by late January 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Credit Suisse Remains Sidelined on Humana (HUM) After Meeting with Management
August 16, 2016 11:00 AM EDTCredit Suisse reiterated a Neutral rating on Humana (NYSE: HUM), and raised the price target to $188.00 (from $175.00), after meeting with the company's CFO and VP/IR.
Analyst Scott Fidel commented, "We hosted HUM's CFO and VP/IR for investor meetings in NYC. Relative to AET deal, HUM believes it has... More
